Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Magpie101
    Junior Member
    • Jun 2016
    • 2

    #1

    Coverage Estimates from Masked/Unmasked Genome

    Hi All,

    I've carried out a mapping run with Illumina paired-end reads to a genome using BWA. From this I've calculated i) x times coverage and ii) fraction of the reference sequence covered to a depth of at least one read. My supervisor now wants me to get coverage metrics which take into account regions that have no read coverage as they are repetitive elements. In essence he just wants coverage stats for the 'mappable' region.

    So, for example, the genome I'm using is c. 2.3Gb in length and c. 50% of this is composed of repeats which reads are unlikely to map to. This will deflate the coverage estimates. So if, say, I have c. 50% of a reference sequence covered at at least 1 read depth; if I minus the 50% of the genome that are repeats then this rises to 100%. What I'm trying to figure out is if I know the annotations info for the repetitive elements can I figure this out with my existing .bam file or will I need to remap to a hard-masked genome or remove the repetitive elements somehow and then figure it out.

    I really hope this makes sense (I suspect not!).

    Thanks
    Last edited by Magpie101; 11-04-2016, 11:09 AM.
  • atcghelix
    Member
    • Jul 2013
    • 74

    #2
    The samtools "depth" command should output the coverage at only the bases that have a depth of at least 1 if that's what you want.

    But this is conceptually different than filtering out repetitive regions based on the annotations you have.

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      Use GEM to determine the mappable regions and then determine coverage accordingly.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 12:22 PM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...